Roche vs BB Biotech vs Pfizer vs FMC
Side-by-side comparison of 4 dividend stocks — yield, growth, safety.
Reviewed byLupe Editorial
·Data refreshed
·SourceEOD Historical Data — Dividends, EOD Historical Data — Fundamentals, EOD Historical Data
| Metric | Roche CH0012032048 | BB Biotech CH0038389992 | Pfizer US7170811035 | FMC DE0005785604 |
|---|---|---|---|---|
| Sector | Health Care | Health Care | Health Care | Health Care |
| Country | CH | CH | US | DE |
| Market Cap | – | – | – | – |
| Current Price | CHF 312.00 | CHF 44.85 | $26.48 | €36.73 |
| Dividend Yield | 3.14% | 5.02% | 4.87% | 4.06% |
| Dividend (TTM) | CHF 9.80 | CHF 2.25 | $1.29 | €1.49 |
| Increase Streak | 26 yrs | 0 yrs | 15 yrs | 2 yrs |
| Growth (5y CAGR) | 1.51% | -11.94% | 3.59% | 1.85% |
| Frequency | Final | Final | Quarterly | Final |
| Next Ex-Date | – | – | – | – |
| Payout Ratio | – | – | – | – |
| FCF Coverage | – | – | – | – |
| Net Debt / EBITDA | – | – | – | – |
| Safety Score | 22/100 | 7/100 | 19/100 | 11/100 |
| Verdict | Monitor | Monitor | Monitor | Monitor |
★ marks the best value in each metric. Note: for payout ratio and leverage, lower is better.
Dividend Growth Comparison
Indexed to 100 in 2011. Compares growth rates regardless of currency or size.